Metastatic melanoma: an unexpected cause of acute liver failure
- PMID: 39287758
- PMCID: PMC11549103
- DOI: 10.1007/s12328-024-02039-1
Metastatic melanoma: an unexpected cause of acute liver failure
Abstract
Acute liver failure secondary to metastatic melanoma is exceedingly rare with the literature limited to case reports. The disease itself presents with vague symptoms making diagnosis difficult without a high clinical suspicion. Further to this, the prognosis of acute liver failure secondary to metastatic melanoma is dismal. We present the case of a 59-year-old male with a distant history of previously excised cutaneous melanoma who presented to our institution with abdominal pain and liver enzyme derangement suggestive of acute hepatitis. Due to progressive derangement in liver function and cross-sectional imaging suggestive of an infiltrative cause, a left axillary lymph node was biopsied which demonstrated metastatic melanoma. The patient subsequently deteriorated into acute liver failure and despite acute treatment of his underlying metastatic melanoma died 17 days post initial presentation. This case highlights an uncommon cause of acute liver failure as well as the poor prognosis associated with acute liver failure secondary to metastatic melanoma.
Keywords: Acute liver failure; Hepatitis; Melanoma; Metastatic melanoma.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests. Ethics approval was not required for this study. The patient provided written consent.
Figures
References
-
- Curti BD, Leachman S, Urba WJ. Cancer of the Skin. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison’s principles of internal medicine. 20th ed. New York (NY): McGraw-Hill Education; 2018. p. 522–30.
-
- SEER S. Explorer: An Interactive Website for SEER Cancer Statistics. Surveillance Research Program, National Cancer Institute. Available online: Accessed 27 Sept 2021
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
